About
- Level: Lab Advisory: Enforcement Discretion Granted for the Use of Conjunctival Swabs with the ÐÇ¿ÕÓéÀÖ¹ÙÍø Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A/H5 Subtyping Kit
- Audience: Clinical Laboratory Professionals
Lab Advisory: Enforcement Discretion Granted for the Use of Conjunctival Swabs with the ÐÇ¿ÕÓéÀÖ¹ÙÍø Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A/H5 Subtyping Kit
On May 24, 2024, the U.S. Food and Drug Administration (FDA) granted enforcement discretion for the use of conjunctival swabs as an acceptable specimen type with the ÐÇ¿ÕÓéÀÖ¹ÙÍø Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A/H5 Subtyping Kit.
Laboratories may now submit conjunctival swabs from patients that meet for novel influenza A virus testing to their state public health laboratories for use with the ÐÇ¿ÕÓéÀÖ¹ÙÍø assay alongside a paired nasopharyngeal swab (NPS). These conjunctival swabs must be collected and transported using the same media as the paired NPS used with the currently cleared ÐÇ¿ÕÓéÀÖ¹ÙÍø kit.
The risk posed by novel influenza A viruses to the public still remains low.
Contact [email protected] for any additional questions, comments, or concerns.
Subscribe to LOCS messages
Contact us
Please use the information below if you have any questions.
- If you are a clinical or public health laboratory professional, contact LOCS.
- For media inquiries, contact the ÐÇ¿ÕÓéÀÖ¹ÙÍø Newsroom.
- For all other questions, .
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
Center for Laboratory Systems and Response (CLSR)
Centers for Disease Control and Prevention (ÐÇ¿ÕÓéÀÖ¹ÙÍø)